雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Effect of switching from prostaglandins and beta-blockers to a fixed combination of travoprost and timolol Izuru Sato 1 , Nobuyoshi Kitaichi 2 , Shigeki Hirose 3 , Mutsuko Takano 4 , Masataka Akanuma 5 , Naoko Tang 6 , Akihiro Tanabe 7 , Heijiro Kinoshita 8 , Yukihiro Horie 9 , Riki Kijima 10 , Takeshi Ohguchi 11 , Masahiko Naka 11 , Takuya Nitta 11 , Yasuhiro Shinmei 11 , Shinki Chin 11 , Susumu Ishida 11 1Dept of Ophthalmol,NTT EAST Sapporo Hosp 2Dept of Ophthalmol,Health Sci Univ of Hokkaido 3Dept of Ophthalmol,Sapporo Social Insurance Gen Hosp 4Dept of Ophthalmol,Hakodate Cent Gen Hosp 5Dept of Ophthalmol,Sunagawa City Med Cent 6Dept of Ophthalmol,KKR Sapporo Med Cent 7Dept of Ophthalmol,Nakashibetsu Town Hosp 8Dept of Ophthalmol,Takikawa Mun Hosp 9Dept of Ophthalmol,Obihiro Kyokai Hosp 10Dept of Ophthalmol,Hurano Kyokai Hosp 11Dept of Ophthalmol,Hokkaido Univ Grad Sch of Med pp.675-678
Published Date 2012/5/15
DOI https://doi.org/10.11477/mf.1410104202
  • Abstract
  • Look Inside
  • Reference

Abstract. Purpose:To report the outcome of switching from prostaglandins and beta-blockers to a fixed combination of travoprost and timolol for glaucoma. Cases and Method:This prospective study was made in 11 institutions on 78 eyes of 40 patients with open-angle glaucoma who were under treatment with topical prostaglandins and beta-blockers. The treatment was switched to a fixed combination of travoprost and timolol. Intraocular pressure(IOP)was measured before and after treatment. Patients were asked by questionnaire after switching. Results:IOP averaged 15.2±3.7 mmHg before switching. It decreased significantly to 14.3±3.4 mmHg two months after switching and to 14.1±3.4 mmHg six months after switching. Response to questionnaire was obtained from 23 patients. Ease of self-medication was reported by 18 patients. Twelve patients forgot to apply the medication less frequently. Conclusion:The fixed combination of travoprost and timolol in this study promises to further reduce IOP and to improve the adherence in glaucoma patients.


Copyright © 2012, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1882-1308 印刷版ISSN 0370-5579 医学書院

関連文献

もっと見る

文献を共有